Related Experiment Video
Updated: Mar 20, 2026

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
Published on: November 27, 2019
RKIP expression of liver and kidney after arsenic exposure
Der-An Tsao1, Wei-Chang Tseng1, Huoy-Rou Chang2
1Department of Medical Technology, Institute of Medical Technology, Fooyin University, Kaohsiung, Taiwan.
Abstract:
Arsenic is associated with cancers of kidney and liver. Raf kinase inhibitor protein (RKIP) has been identified as a member of a novel class of molecules that suppress the metastatic spread of tumors. In order to investigate the effect of arsenic to RKIP of liver and kidney, the expression of RKIP of liver and kidney with As (III) was explored in this study. Thirty male mice were chronically fed with 42.5 ppm, 85 ppm NaAsO2 and water for 180 days. The kidney and liver accumulation levels of As (III) in mice were determined by electro-thermal atomic absorption spectrometry. The method of RT-PCR, Western blotting analysis and immunohistochemistry were used to determine gene expression and protein expression of RKIP. The results showed that arsenic level was significantly increased in kidney and liver of As (III)-exposed mice as compared with control group. The gene expression and protein expression of RKIP was significantly decreased in kidney and liver of As (III)-exposed mice in comparison with these of control mice. These data suggested that RKIP decrease of liver and kidney with As (III) may be dangerous index in formation of cancer. © 2016 Wiley Periodicals, Inc. Environ Toxicol 32: 1079-1082, 2017.
Insights
Chronic arsenic exposure in mice significantly reduced Raf kinase inhibitor protein (RKIP) in the liver and kidney. This decrease in RKIP may indicate a higher risk for cancer development.
Area of Science:
- Environmental Toxicology
- Molecular Biology
- Cancer Research
Background:
- Arsenic exposure is linked to kidney and liver cancers.
- Raf kinase inhibitor protein (RKIP) inhibits tumor metastasis.
Purpose of the Study:
- To investigate the impact of arsenic (As (III)) on RKIP expression in mouse liver and kidney.
- To assess if arsenic exposure affects RKIP levels, potentially contributing to cancer formation.
Main Methods:
- Mice were exposed to sodium arsenite (NaAsO2) for 180 days.
- Arsenic accumulation in kidney and liver was measured using electro-thermal atomic absorption spectrometry.
- Gene and protein expression of RKIP were determined via RT-PCR, Western blotting, and immunohistochemistry.
Main Results:
- Arsenic levels significantly increased in the kidneys and livers of exposed mice.
- Both gene and protein expression of RKIP were significantly decreased in the liver and kidney of arsenic-exposed mice compared to controls.
Conclusions:
- Arsenic exposure downregulates RKIP expression in the liver and kidney.
- Reduced RKIP levels due to arsenic exposure may serve as a potential biomarker for cancer risk.
Related Concept Videos
Acute Kidney Injury I: Introduction
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury II: Pathophysiology

